Valuation: Prenetics Global Limited

Market Cap 175M 159M 147M 133M 250M 16.31B 262M 1.78B 706M 8.81B 655M 641M 27.92B P/E 2026 *
-2.2x
P/E 2027 * -3.46x
Enterprise Value 175M 159M 147M 133M 250M 16.31B 262M 1.78B 706M 8.81B 655M 641M 27.92B EV / Sales 2026 *
0.78x
EV / Sales 2027 * 0.43x
Free-Float
81.74%
Yield 2026 *
-
Yield 2027 * -
1 day-0.39%
1 week-41.55%
Current month-41.95%
1 month-44.33%
3 months-46.86%
6 months-29.09%
Current year-34.54%
1 week 9.13
Extreme 9.1343
17.74
1 month 9.13
Extreme 9.1343
19.88
Current year 9.13
Extreme 9.1343
27.24
1 year 9.13
Extreme 9.1343
27.24
3 years 2.85
Extreme 2.85
27.24
5 years 2.85
Extreme 2.85
131.25
10 years 2.85
Extreme 2.85
131.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 52 01/01/2014
Chief Executive Officer 47 01/01/2014
Director of Finance/CFO 41 01/01/2018
Director TitleAgeSince
Chairman 47 01/01/2014
Director/Board Member 38 -
Director/Board Member - 16/02/2026
Date Insider Type Main position Quantity % Market Cap. Importance
4/11/26 Exercice

Director

4,000 0.0260%
4/10/26 Exercice

Director

4,000 0.0257%
30/9/26 Exercice

Chief Financial Officer

15,270 0.0981%
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-41.55%-16.28%+122.68% 175M
-0.58%-4.96%-20.10%+4.34% 181B
-0.11%-0.98%-0.19%+34.58% 123B
-1.59%-1.79%-12.92%+8.57% 121B
-2.21%-3.15%-43.22%-1.44% 91.11B
-2.03%-2.47%-5.64%+75.00% 66.47B
-1.57%-0.86%+10.58%-8.83% 58.86B
-1.26%-1.84%+2.90%+48.73% 55.03B
-1.40%-3.34%+2.13%+40.44% 48.88B
+1.60%+6.46%+5.64%+1.34% 35.5B
Average -0.89%-4.39%-7.71%+32.54% 78B
Weighted average by Cap. -0.97%-1.13%-10.82%+19.39%

Financials

2026 *2027 *
Net sales 223M 203M 188M 170M 319M 20.82B 334M 2.27B 901M 11.25B 836M 819M 35.63B 406M 370M 342M 309M 581M 37.89B 608M 4.14B 1.64B 20.47B 1.52B 1.49B 64.85B
Net income -81.37M -74.13M -68.62M -62.07M -116M -7.6B -122M -830M -329M -4.11B -305M -299M -13.01B -52.88M -48.18M -44.6M -40.34M -75.68M -4.94B -79.21M -539M -214M -2.67B -198M -194M -8.45B
Net Debt - -
Projected Income Statement - Annual - Prenetics Global Limited
Logo Prenetics Global Limited
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Employees
98
Date Price Change Volume
19/11/26 US$10.31 -0.39% 820,940
18/11/26 US$10.35 -36.62% 1,578,068
17/11/26 US$16.33 +5.49% 218,368
16/11/26 US$15.48 -6.24% 169,001
13/11/26 US$16.51 -1.26% 151,791
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Prenetics Global Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
10.31USD
Average target price
36.22USD
Spread / Average Target
+251.33%